Angiology and Blood Coagulation Unit, S. Orsola-Malpighi University Hospital, 40138 Bologna, Italy.
Angiology and Blood Coagulation Unit, S. Orsola-Malpighi University Hospital, 40138 Bologna, Italy.
Thromb Res. 2017 Jul;155:72-77. doi: 10.1016/j.thromres.2017.05.008. Epub 2017 May 9.
Intracranial atherosclerotic disease (ICAD) is responsible for at least 10% of transient ischaemic attacks (TIA). Thrombin generation has been shown to be associated with several atherosclerotic conditions and may be relevant in the pathogenesis of TIA from ICAD.
To evaluate the association between thrombin generation and ICAD in patients with TIA.
Consecutive patients with confirmed diagnosis of TIA by vascular neurologist were enrolled. Within 24h from diagnosis, all the patients underwent: blood samples including thrombin generation search, electrocardiography, brain CT scan, blood pressure (BP) measurement, supra-aortic echo-Doppler, transcranial Doppler (TCD) and standard echocardiogram. Thrombin generation was measured as endogenous thrombin potential (ETP) in platelet-rich plasma (PRP) and in platelet-poor plasma (PPP), in the presence and in the absence of thrombomodulin (TM).
120 patients (male 52.5%), aged 69±16years were enrolled. Ten patients on warfarin treatment had significantly lower ETP than the others. Among the remaining, ETP in the presence or absence of TM did not differ according to TOAST classification aetiology (large vessel vs. cardioembolic vs. lacunar vs. others). In PRP, ETP was similar in patients with ICAD and in those without (1748±160 vs. 1851±36nM·min, p=0.393), whereas, ETP measured in presence of thrombomodulin was higher in patients with than in those without ICAD (2045±99 vs. 1715±41nM·min, p=0.011). In PPP, ETP was similar in patients with ICAD and in those without, whereas thrombin peak was higher in patients with ICAD than in those without both in the presence (165±17 vs. 130±5nM, p=0.036) and in the absence of TM (178±19 vs. 142±5nM, p=0.037).
ETP measured in presence of TM is enhanced in patients with ICAD, supporting that thrombomodulin-protein C pathways is relevant in TIA from ICAD. These hypothesis-generating data suggest that thrombin generation may be relevant in cerebral ischaemia from intracranial disease, and justify larger studies.
颅内动脉粥样硬化性疾病(ICAD)占短暂性脑缺血发作(TIA)的至少 10%。已有研究表明,凝血酶生成与多种动脉粥样硬化疾病相关,可能与 ICAD 所致 TIA 的发病机制有关。
评估凝血酶生成与 TIA 患者 ICAD 之间的相关性。
连续纳入经血管神经病学家确诊的 TIA 患者。在诊断后 24 小时内,所有患者均接受以下检查:包括凝血酶生成搜索在内的血液样本、心电图、脑 CT 扫描、血压(BP)测量、主动脉超声心动图、经颅多普勒(TCD)和标准超声心动图。凝血酶生成以富含血小板的血浆(PRP)和富含血小板的血浆(PPP)中的内源性凝血酶潜能(ETP)来测量,同时检测有和无血栓调节蛋白(TM)的情况。
共纳入 120 例患者(男性 52.5%),年龄 69±16 岁。10 例正在服用华法林的患者的 ETP 明显低于其他患者。在其余患者中,无论 TM 存在与否,根据 TOAST 病因分类(大动脉 vs. 心源性栓塞 vs. 腔隙性 vs. 其他),ETP 均无差异。在 PRP 中,ICAD 患者与非 ICAD 患者的 ETP 相似(1748±160 vs. 1851±36nM·min,p=0.393),而存在 TM 时,ICAD 患者的 ETP 高于非 ICAD 患者(2045±99 vs. 1715±41nM·min,p=0.011)。在 PPP 中,ICAD 患者与非 ICAD 患者的 ETP 相似,而凝血酶峰值在存在 TM 时(165±17 vs. 130±5nM,p=0.036)和不存在 TM 时(178±19 vs. 142±5nM,p=0.037)均高于非 ICAD 患者。
在 ICAD 患者中,存在 TM 时的 ETP 升高,提示血栓调节蛋白-蛋白 C 途径与 ICAD 所致 TIA 相关。这些产生假说的数据表明,凝血酶生成可能与颅内疾病引起的脑缺血有关,并证明了更大规模研究的合理性。